Back to search

Article

NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer

2019-08-27

Abstract excerpt

<title>Abstract</title> <p>Background NRF2 overexpression confers poor prognosis in some cancers but its prognostic role in colorectal cancer (CRC) is unknown. As a transcription factor, we hypothesise a signature of NRF2 regulated genes could act as a prognostic biomarker in CRC and reveal novel biological insights.Methods Using known NRF2 regulated genes, differentially expressed in CRC, we defined a signature...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d8bc883a-53c9-5d26-b08a-e24441bcd9b9
DOI
10.21203/rs.2.13614/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
NRF2 metagene signature is a novel prognostic biomarker in colorectal cancerDOI 10.21203/rs.2.13614/v1
Select a neighboring publication to make it the new centre.